FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178794390> ?p ?o ?g. }

• W3178794390 endingPage "T140" @default.
• W3178794390 startingPage "T125" @default.
• W3178794390 abstract "The treatment of differentiated thyroid cancer continues to move away from a 'one size fits all' approach to a process of tailored therapeutic decision-making that incorporates disease-specific factors and individual patient preferences. Management options range from active surveillance to thyroid lobectomy to total thyroidectomy with or without the use of postoperative radioactive iodine (RAI). RAI may be administered for one or more reasons: Thyroid remnant ablation, adjuvant therapy, or therapy for persistent structural disease. It is important to be cognizant of the therapeutic intent of RAI and weigh the risks and benefits of treatment for each individual patient. Risk stratification should be used to identify those patients who are most likely to benefit from RAI and guide therapeutic choices. Available data suggest that RAI can be safely deferred for most patients considered at low risk for structural recurrence, while adjuvant RAI is associated with improved disease-free survival in patients with higher-risk disease. Although progress has been made, many areas of uncertainty related to the use of RAI remain. These include: (1) The appropriate selection of intermediate-risk patients to receive adjuvant RAI, (2) the superiority or inferiority of different RAI dosing activities, (3) the optimal approach to the use of RAI in special populations, including patients with end-stage renal disease and children, and (4) the management of patients with RAI-refractory disease." @default.
• W3178794390 created "2021-07-19" @default.
• W3178794390 creator A5073085667 @default.
• W3178794390 creator A5081785448 @default.
• W3178794390 creator A5088416416 @default.
• W3178794390 date "2021-10-01" @default.
• W3178794390 modified "2023-10-12" @default.
• W3178794390 title "Tailoring the approach to radioactive iodine treatment in thyroid cancer" @default.
• W3178794390 cites W1772318814 @default.
• W3178794390 cites W179995436 @default.
• W3178794390 cites W1945762684 @default.
• W3178794390 cites W1968424436 @default.
• W3178794390 cites W1977718854 @default.
• W3178794390 cites W1979883969 @default.
• W3178794390 cites W1986340809 @default.
• W3178794390 cites W1986531739 @default.
• W3178794390 cites W1987472852 @default.
• W3178794390 cites W1990970667 @default.
• W3178794390 cites W1991897722 @default.
• W3178794390 cites W1998362237 @default.
• W3178794390 cites W2010997285 @default.
• W3178794390 cites W2021270934 @default.
• W3178794390 cites W2022202489 @default.
• W3178794390 cites W2026390338 @default.
• W3178794390 cites W2033297297 @default.
• W3178794390 cites W2040165720 @default.
• W3178794390 cites W2042039696 @default.
• W3178794390 cites W2047244262 @default.
• W3178794390 cites W2048186624 @default.
• W3178794390 cites W2059731641 @default.
• W3178794390 cites W2062540411 @default.
• W3178794390 cites W2065271250 @default.
• W3178794390 cites W2066653895 @default.
• W3178794390 cites W2112027306 @default.
• W3178794390 cites W2113624266 @default.
• W3178794390 cites W2113637323 @default.
• W3178794390 cites W2115297750 @default.
• W3178794390 cites W2120775347 @default.
• W3178794390 cites W2121559216 @default.
• W3178794390 cites W2143439321 @default.
• W3178794390 cites W2145560441 @default.
• W3178794390 cites W2169470178 @default.
• W3178794390 cites W2171937766 @default.
• W3178794390 cites W2236417624 @default.
• W3178794390 cites W2265766730 @default.
• W3178794390 cites W2272603941 @default.
• W3178794390 cites W2409794844 @default.
• W3178794390 cites W2463933832 @default.
• W3178794390 cites W2536889135 @default.
• W3178794390 cites W2609508713 @default.
• W3178794390 cites W2609784945 @default.
• W3178794390 cites W2725871203 @default.
• W3178794390 cites W2750808457 @default.
• W3178794390 cites W2765084664 @default.
• W3178794390 cites W2788816018 @default.
• W3178794390 cites W2803140629 @default.
• W3178794390 cites W2806489760 @default.
• W3178794390 cites W2809616582 @default.
• W3178794390 cites W2829841267 @default.
• W3178794390 cites W2891131732 @default.
• W3178794390 cites W2899705225 @default.
• W3178794390 cites W2903038485 @default.
• W3178794390 cites W2903421261 @default.
• W3178794390 cites W2927301035 @default.
• W3178794390 cites W2944948929 @default.
• W3178794390 cites W3019053517 @default.
• W3178794390 cites W3040917057 @default.
• W3178794390 cites W3094538101 @default.
• W3178794390 cites W3133816002 @default.
• W3178794390 cites W3148272858 @default.
• W3178794390 cites W2056349486 @default.
• W3178794390 doi "https://doi.org/10.1530/erc-21-0161" @default.
• W3178794390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34254949" @default.
• W3178794390 hasPublicationYear "2021" @default.
• W3178794390 type Work @default.
• W3178794390 sameAs 3178794390 @default.
• W3178794390 citedByCount "13" @default.
• W3178794390 countsByYear W31787943902021 @default.
• W3178794390 countsByYear W31787943902022 @default.
• W3178794390 countsByYear W31787943902023 @default.
• W3178794390 crossrefType "journal-article" @default.
• W3178794390 hasAuthorship W3178794390A5073085667 @default.
• W3178794390 hasAuthorship W3178794390A5081785448 @default.
• W3178794390 hasAuthorship W3178794390A5088416416 @default.
• W3178794390 hasBestOaLocation W31787943901 @default.
• W3178794390 hasConcept C121608353 @default.
• W3178794390 hasConcept C126322002 @default.
• W3178794390 hasConcept C141071460 @default.
• W3178794390 hasConcept C143998085 @default.
• W3178794390 hasConcept C177713679 @default.
• W3178794390 hasConcept C2777074255 @default.
• W3178794390 hasConcept C2777288759 @default.
• W3178794390 hasConcept C2777863537 @default.
• W3178794390 hasConcept C2777982462 @default.
• W3178794390 hasConcept C2779134260 @default.
• W3178794390 hasConcept C2779761222 @default.
• W3178794390 hasConcept C2908975369 @default.
• W3178794390 hasConcept C526584372 @default.

• next